Skip to main content

Advertisement

SpringerLink
Log in

Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Aims

Thymidylate synthase (TS) and tumor suppressor p53 are two proteins with an influence on tumor resistance to radio-chemotherapy that is well known. For this reason we tested the effect of TS and p53 expression on clinical outcome (tumor recurrence and survival) in patients after curative tumor resection, especially in patients who received adjuvant radio-chemotherapy.

Patients and methods

A total of 120 patients with colorectal cancer were included in the study. A curative resection was possible in 83 patients, and 30 of this group received adjuvant therapy. For the immunohistochemical staining of tumor specimens, monoclonal antibody (mAb) TS 106 against TS and mAb DO-1 against p53 protein were used. TS positivity was defined as a moderate to high staining intensity in the cytoplasma of cells and p53 positivity as nuclear staining of tumor cells in >10% of these cells.

Results

Thymidylate synthase immunoreactivity was found in 59% of all cases and p53 staining in 51%. No relation between clinicopathological features and p53 expression was found in contrast to TS expression, where a highly significant association of TS-positive cases with tumor invasion (pT) was observed. Curatively resected patients with a TS-positive tumor developed tumor recurrence/distant metastases significantly more often than TS negative tumors. The same result was found when comparing p53-positive with p53-negative tumors and TS+/p53+ with TS−/p53− tumors. TS expression was highly significantly associated with poor survival and was the strongest independent prognostic factor in multivariate analysis, followed by lymph node status.

Conclusion

Thymidylate synthase expression seems to be an independent prognostic factor and a possible predictor of tumor recurrence in patients with colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. American Cancer Society (1996) Cancer facts and figures. American Cancer Society, New York

  2. National Institutes of Health (1990) NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 264:1444–1450

    Google Scholar 

  3. Drake JC, Voeller DM, Allegra CJ, Johnston PG (1995) The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells. Br J Cancer 71:1145–1150

    CAS  PubMed  Google Scholar 

  4. Peters GJ, van der Wilt CL, van Triest B, Codacci-Pisanelli G, Johnston PG, van Groeningen CJ, Pinedo HM (1995) Thymidylate synthase and drug resistance. Eur J Cancer 31A:1299–1305

    Article  CAS  PubMed  Google Scholar 

  5. Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H, Seeber S (1997) Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J Clin Oncol 15:389–400

    CAS  PubMed  Google Scholar 

  6. Kase S, Kubota T, Watanabe M, Takahara T, Takeuchi T, Yamaguchi H, Furukawa T, Teramoto T, Kodaira S, Ishibiki K (1993) The modulation by l-leucovorin of 5-fluorouracil antitumor activity on human colon carcinoma cells in vitro and in vivo. Surg Today 23:615–620

    CAS  PubMed  Google Scholar 

  7. Pizzorno G, Sun Z, Handschumacher RE (1995) Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil. Biochem Pharmacol 49:553–557

    Article  CAS  PubMed  Google Scholar 

  8. Johnston PG, Liang CM, Henry S, Chabner BA, Allegra CJ (1991) Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51:6668–6676

    CAS  PubMed  Google Scholar 

  9. Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, Chabner BA, Allegra CJ (1994) The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12:2640–2647

    Google Scholar 

  10. Benhattar J, Cerottini JP, Saraga E, Metthez G, Givel JC (1996) p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int J Cancer 69:190–192

    Article  CAS  PubMed  Google Scholar 

  11. Nabeya Y, Loganzo F, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP (1995) The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int J Cancer 64:37–46

    CAS  PubMed  Google Scholar 

  12. Luna-Perez P, Arriola EL, Cuadra Y, Alvarado I, Quintero A (1998) p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma. Ann Surg Oncol 5:203–208

    CAS  PubMed  Google Scholar 

  13. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266:807–810

    Google Scholar 

  14. O’Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW (1993) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt’s lymphoma cell lines. Cancer Res 53:4776–4780

    PubMed  Google Scholar 

  15. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311

    CAS  PubMed  Google Scholar 

  16. Lee Y, Chen Y, Chang LS, Johnson LF (1997) Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein. Exp Cell Res 234:270–276

    Article  CAS  PubMed  Google Scholar 

  17. Bruch HP, Schwandner O, Keller R, Farke S, Schiedeck THK (2003) Surgical therapy for rectal cancer. Chirurgia 74:905–914

    Article  Google Scholar 

  18. Sterk P, Kasperk R, Opitz T, Schubert F, Klein P (2000) Vascular organization in the mesorectum: angiography of rectal resection specimens. Int J Colorectal Dis 15:225–228

    Article  CAS  PubMed  Google Scholar 

  19. Herfarth C, Runkel N (1994) Surgical standards in primary colorectal carcinoma. Chirurgia 65:514–523

    CAS  Google Scholar 

  20. Hermanek P, Sobin LH (eds) (1992) TNM classification of malignant tumours, 4th edn, 2nd rev. Springer, Berlin Heidelberg New York

  21. Junginger T (Hrsg) (1997) Grundlagen der Chirurgie (G76): Leitlinien zur Therapie des Kolonkarzinoms. Demeter, Balingen

  22. Junginger T (Hrsg) (1997) Grundlagen der Chirurgie (G78): Leitlinien zur Therapie des Rektumkarzinoms. Demeter, Balingen

  23. Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L (1995) Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 14:176–182

    Google Scholar 

  24. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M, Danenberg PV (1997) Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15:3223–3229

    CAS  PubMed  Google Scholar 

  25. Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ, Johnston P-G (2000) Thymidylate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567

    Article  CAS  PubMed  Google Scholar 

  26. Lenz HJ, Hayashi K, Salonga D, Danenberg KD, Danenberg PV, Metzger R, Banerjee D, Bertino JR, Groshen S, Leichman LP, Leichman CG (1998) p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. Clin Cancer Res 4:1243–1250

    CAS  PubMed  Google Scholar 

  27. Chu E, Copur S, Jones KL, Khleif S, Voeller D, Maley GF, Maley F, Allegra CJ (1995) Thymidylate synthase regulates the translation of p53 mRNA. Proc Am Assoc Cancer Res 36:563

    Google Scholar 

  28. Kinsella AR, Smith D, Pickard M (1997) Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. Br J Cancer 75:935–945

    CAS  PubMed  Google Scholar 

  29. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B (1994) Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer 57:1–9

    Google Scholar 

  30. Edler D, Hallström M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H (2000) Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res 6:1378–1384

    CAS  PubMed  Google Scholar 

  31. Lenz HJ, Danenberg KD, Leichman CG, Florentine B, Johnston PG, Groshen S, Zhou L, Xiong YP, Danenberg PV, Leichman LP (1998) p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clin Cancer Res 4:1227–1234

    CAS  PubMed  Google Scholar 

  32. Takenoue T, Nagawa H, Matsuda K, Fujii S, Nita ME, Hatano K, Kitayama J, Tsuruo T, Muto T (2000) Relation between thymidylate synthase expression and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by immunohistochemical method. Ann Surg Oncol 7:193–198

    CAS  PubMed  Google Scholar 

  33. Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, Inoue M, Tatematsu M (1998) A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 82:70–77

    CAS  PubMed  Google Scholar 

  34. Smith DR, Goh HS (1996) p53 and prognosis in colorectal cancer. Ann Acad Med Singapore 25:107–112

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Mrs C. Killaitis for statistical evaluation of the data, and Mrs G. Grosser-Pape for technical assistance.

Author information

Authors and Affiliations

  1. Surgical Research Laboratory, University Clinic of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany

    R. Broll, P. Busch, M. Duchrow & U. Windhövel

  2. Surgical Clinic, University Clinic of Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany

    E. Oevermann, O. Schwandner, S. Farke & H. P. Bruch

Authors
  1. R. Broll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Busch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Duchrow
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Oevermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. Schwandner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Farke
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. P. Bruch
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. U. Windhövel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Broll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Broll, R., Busch, P., Duchrow, M. et al. Influence of thymidylate synthase and p53 protein expression on clinical outcome in patients with colorectal cancer. Int J Colorectal Dis 20, 94–102 (2005). https://doi.org/10.1007/s00384-004-0621-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-004-0621-5

Keywords

Search

Navigation